Cargando…
Weight Loss at First Month and Development of Tolerance as Possible Predictors of 30 mg Phentermine Efficacy at 6 Months
The efficacy of anti-obesity drugs usually does not consider the high degree of interindividual variability in responses to the drug which could affect the decision to withdraw the drug early due to ineffectiveness or to continue therapy according to specific expectations of success. The aim of this...
Autores principales: | Rocha-González, Héctor Isaac, De la Cruz-Álvarez, Lidia Elizabeth, Kammar-García, Ashuin, Canizales-Quinteros, Samuel, Huerta-Cruz, Juan Carlos, Barranco-Garduño, Lina Marcela, Reyes-García, Juan Gerardo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8707701/ https://www.ncbi.nlm.nih.gov/pubmed/34945825 http://dx.doi.org/10.3390/jpm11121354 |
Ejemplares similares
-
Three- and six-month efficacy and safety of phentermine in a Mexican obese population
por: Márquez-Cruz, Maribel, et al.
Publicado: (2021) -
Combined First Month Body Weight Loss and Development of Tolerance as Predictors of 6-Month Efficacy of Mazindol in Mild and Moderate Obese Subjects
por: Huerta-Cruz, Juan Carlos, et al.
Publicado: (2022) -
Metformin improves the weight reduction effect of mazindol in prediabetic obese Mexican subjects
por: Arguelles-Tello, Federico Alberto, et al.
Publicado: (2022) -
Effect of the Melanocortin 4-Receptor Ile269Asn Mutation on Weight Loss Response to Dietary, Phentermine and Bariatric Surgery Interventions
por: Salazar-Valencia, Itzel G., et al.
Publicado: (2022) -
Dietary Patterns and Their Association with Metabolic Syndrome and Their Components in Middle-Class Adults from Damascus, Syria: A Cross-Sectional Study
por: Atasi, Malda, et al.
Publicado: (2022)